de Man RA - Search Results

1

Hepatitis E virus infection activates NOD-like receptor family pyrin domain-containing 3 inflammasome antagonizing interferon response but therapeutically targetable.

Li Y, Yu P, Kessler AL, Shu J, Liu X, Liang Z, Liu J, Li Y, Li P, Wang L, Wang Y, Ma Z, Liu A, Wang L, Bruno MJ, de Man RA, Peppelenbosch MP, Buschow SI, Wang L, Wang Y, Pan Q. Li Y, et al. Among authors: de man ra. Hepatology. 2022 Jan;75(1):196-212. doi: 10.1002/hep.32114. Epub 2021 Dec 5. Hepatology. 2022. PMID: 34392558 Free PMC article.

2

Anti-hepatitis B virus activity of a mixture of two monoclonal antibodies in an "inhibition in solution" assay.

Heijtink RA, Kruining J, Weber YA, de Man RA, Schalm SW. Heijtink RA, et al. Among authors: de man ra. Hepatology. 1995 Oct;22(4 Pt 1):1078-83. doi: 10.1016/0270-9139(95)90612-6. Hepatology. 1995. PMID: 7557854

3

Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine.

Honkoop P, de Man RA, Zondervan PE, Schalm SW. Honkoop P, et al. Among authors: de man ra. Liver. 1997 Apr;17(2):103-6. doi: 10.1111/j.1600-0676.1997.tb00789.x. Liver. 1997. PMID: 9138281 Clinical Trial.

4

Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.

Honkoop P, Niesters HG, de Man RA, Osterhaus AD, Schalm SW. Honkoop P, et al. Among authors: de man ra. J Hepatol. 1997 Jun;26(6):1393-5. doi: 10.1016/s0168-8278(97)80476-x. J Hepatol. 1997. PMID: 9210628

5

Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B.

Honkoop P, de Man RA, Scholte HR, Zondervan PE, Van Den Berg JW, Rademakers LH, Schalm SW. Honkoop P, et al. Among authors: de man ra. Hepatology. 1997 Jul;26(1):211-5. doi: 10.1002/hep.510260128. Hepatology. 1997. PMID: 9214472 Clinical Trial.

6

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.

Honkoop P, de Man RA, Niesters HG, Zondervan PE, Schalm SW. Honkoop P, et al. Among authors: de man ra. Hepatology. 2000 Sep;32(3):635-9. doi: 10.1053/jhep.2000.16333. Hepatology. 2000. PMID: 10960461

7

Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection.

de Man RA, Wolters LM, Nevens F, Chua D, Sherman M, Lai CL, Gadano A, Lee Y, Mazzotta F, Thomas N, DeHertogh D. de Man RA, et al. Hepatology. 2001 Sep;34(3):578-82. doi: 10.1053/jhep.2001.26815. Hepatology. 2001. PMID: 11526545 Clinical Trial.

8

Nucleoside analogues for chronic hepatitis B.

Wolters LM, Niesters HG, de Man RA. Wolters LM, et al. Among authors: de man ra. Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1499-506. doi: 10.1097/00042737-200112000-00016. Eur J Gastroenterol Hepatol. 2001. PMID: 11742201 Review.

9

Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.

Wolters LM, Hansen BE, Niesters HG, DeHertogh D, de Man RA. Wolters LM, et al. Among authors: de man ra. J Hepatol. 2002 Jul;37(1):137-44. doi: 10.1016/s0168-8278(02)00115-0. J Hepatol. 2002. PMID: 12076873

10

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.

van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL. van Zonneveld M, et al. Among authors: de man ra. Hepatology. 2004 Mar;39(3):804-10. doi: 10.1002/hep.20128. Hepatology. 2004. PMID: 14999700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

489 results

Search Page